Bausch Health (BHC) Q2 Earnings In Line, Xifaxan Boosts Sales

Bausch Health Companies Inc.'s (BHC) reported second-quarter adjusted earnings per share of 89 cents, on par with the Zacks Consensus Estimate. The reported figure increased from 81 cents in the year-ago quarter due to higher revenues. Total revenues of $2.4 billion were up 11$2.3 billion. Excluding the impact of foreign exchange of $25 million, acquisitions of$104 million, and divestitures and discontinuations of $14 million, revenue ...